Protocol for Hematoxylin-Eosin (H&E) Staining

Reagents and chemicals

• Use fixed paraffin-embedded tissue sections or cell/organoid blocks as the sample, xylene or validated dewaxing agent for deparaffinization, graded ethanol for rehydration and dehydration, hematoxylin for nuclear staining, eosin for cytoplasmic and extracellular counterstaining, clearing agent, and permanent mounting medium^[1][2].

• Use 10% neutral buffered formalin for routine FFPE morphology when compatible with downstream assays; alternative fixation should be selected only when specifically required, such as ethanol fixation for preserving native fluorescent reporter proteins^[4][5].

Dyes, or kits

• Hematoxylin and eosin are the essential dyes^[1][2].

Cells, tissues, isolated organs, organoids, or animals

• Use excised mouse tumors, intestinal organoids embedded as sections or cell blocks, cultured cancer-cell pellets, inflammatory macrophage cell blocks, primary-neuron tissue samples, or drug-treated tissues when the goal is morphology assessment^[3][6].

Buffers and solutions

• Use fixation solution, graded alcohols, water, hematoxylin, bluing solution when included in the validated staining workflow, eosin, clearing solution, and mounting medium^[1][2].

Equipment and instruments

• Use tissue processor or manual processing setup, paraffin embedding station, microtome, water bath, glass slides, staining jars or automated stainer, fume hood, coverslipper, brightfield microscope, slide scanner, and image-analysis software when quantitative histomorphometry is planned^[2][3].

Controls

• Include a known well-preserved control tissue processed with the same fixation, embedding, sectioning, and staining workflow, plus untreated or vehicle-treated controls for drug-screening experiments^[2][3].

Preparation Steps

• Collect tissue, tumor, organoid, or cell-block samples promptly and fix under a validated condition; 10% neutral buffered formalin for 24 h has been used for mouse liver FFPE histology, while fixation choice and duration can affect morphological interpretation^[4][6].
• Process fixed samples through dehydration, clearing, paraffin infiltration, and embedding, then section at a morphology-appropriate thickness; published H&E studies commonly use thin FFPE sections such as 4-5 µm for diagnostic or experimental histology^[3][4].

Operation Steps

• Bake or dry paraffin sections as required by the local validated workflow, then deparaffinize in xylene or a validated substitute and rehydrate through graded alcohols to water before staining^[1][2].
• Stain nuclei with hematoxylin, rinse, differentiate and blue if included in the validated hematoxylin workflow, then counterstain with eosin to provide cytoplasmic and extracellular contrast; exact staining times should be established and reported for each reagent system because staining quality depends on reagent type and workflow^[1][2].
• Dehydrate stained slides through graded alcohols, clear in xylene or validated clearing agent, and coverslip with permanent mounting medium^[1][2].
• Examine slides by brightfield microscopy or whole-slide scanning and verify that nuclei, cytoplasm, stromal matrix, necrosis, inflammation, and tissue architecture are interpretable before quantitative scoring^[1][3].
• For mouse tumor, organoid, macrophage, neuron, or drug-screening studies, stain all comparison groups in the same batch when possible to reduce staining variability^[2][3].

Data Acquisition and Analysis

• Acquire representative fields or whole-slide images under consistent brightfield settings; analyze morphology qualitatively by a trained observer or quantitatively by predefined histological endpoints such as lesion area, tissue area, inflammatory area, necrosis, epithelial architecture, tumor burden, or atherosclerotic burden when the endpoint is validated for the tissue model^[3].
• Normalize histomorphometric measurements to total tissue area, section length, organoid number, tumor area, or other prespecified denominator appropriate to the biological model, and use biological replicates from independent animals, organoids, cultures, or drug-treated samples^[3].
• Interpret H&E as evidence of morphology and tissue response, not as direct evidence of specific molecular pathways; validate pathway claims with immunohistochemistry, immunofluorescence, Western blot, qPCR, flow cytometry, ferroptosis assays, or mitophagy assays as appropriate^[1][3].

Problem: Poor nuclear-cytoplasmic contrast.

Possible Cause: suboptimal hematoxylin/eosin staining balance or missing staining workflow steps.
Literature-supported Solution: review and standardize the H&E reagent sequence, because omission of individual reagent steps changes staining quality and can impair microscopic interpretation^[2].

Problem: Distorted or poorly preserved morphology.

Possible Cause: inappropriate fixation for the tissue type.
Literature-supported Solution: optimize fixation method and duration for the specimen, because fixation choice has been shown to alter histological preservation and interpretation^[4][6].

Problem: Poor downstream PCR from microdissected H&E slides.

Possible Cause: hematoxylin exposure can reduce PCR amplification from paraffin-section DNA templates.
Literature-supported Solution: avoid hematoxylin-stained sections when the same slide will be used as starting material for PCR-based microdissection studies^[7].

Problem: H&E cannot identify whether vacuoles contain lipid or glycogen.

Possible Cause: routine FFPE H&E processing can remove lipid and glycogen, leaving clear vacuoles.
Literature-supported Solution: use complementary stains such as PAS-based glycogen detection or osmium/PAS approaches when vacuole composition is the endpoint^[8].

Problem: Native fluorescent reporter signal is lost after FFPE processing.

Possible Cause: standard formalin fixation and paraffin processing can inactivate fluorescent reporter proteins.
Literature-supported Solution: use a fixation/embedding method validated to retain native reporter fluorescence when direct reporter imaging is required^[5].